Medical Center Hipokrat 2000 OOD
- Address
- 12-14 Stefan Karadzha Str, 6300 Haskovo, Bulgaria
Medical Center Hipokrat 2000 OOD
Medical Center Hipokrat 2000 OOD is a specialized clinical research facility focused on autoimmune and metabolic disorders. The center demonstrates expertise in conducting complex multinational trials involving both novel therapeutic agents and biosimilar evaluations, with particular emphasis on inflammatory conditions and bone metabolism disorders.
- Rheumatoid arthritis: Long-term safety and efficacy studies with advanced JAK inhibitors
- Inflammatory bowel disease: Combination therapy trials for moderately to severely active ulcerative colitis
- Osteoporosis: Biosimilarity studies in postmenopausal women evaluating bone mineral density outcomes
The facility's research portfolio highlights its capability to manage extended follow-up studies and sophisticated comparative trials. With experience in pharmacokinetic and pharmacodynamic assessments, the center contributes valuable data on therapeutic innovations ranging from targeted immunomodulatory agents to biosimilar bone-protective therapies, supporting evidence-based treatment approaches for chronic autoimmune and skeletal conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical Center Hipokrat 2000 OOD
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Study of Efficacy, Pharmacokinetics, and Safety of Denosumab (MAB-22) Versus EU-Sourced Denosumab in Postmenopausal Osteoporosis | Xentria Inc. | Phase III | Not Recruiting | — | Nov 2025 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Denosumab | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.